A case of interstitial pneumonitis after SARS-CoV-2 mRNA vaccination
Katsuaki Yazawa Shinya Fujii Kenjirou Sato Yu Kusaka Takehiko Oba Susumu Isogai
Department of Pulmonary Medicine, Ome Municipal General Hospital
A 71-year-old woman with no previous medical history was admitted to our hospital with fever and dyspnea following coronavirus disease 19 (COVID-19) mRNA vaccination. Based on her symptoms, physical examination findings, imaging results, and disease course, the diagnosis of vaccine-induced interstitial pneumonitis was made. Treatment with a glucocorticoid relieved her symptoms. The symptoms recurred after a gradual decrease in glucocorticoid over a period of two months. The glucocorticoid was increased to 15 mg and the symptoms subsided. This is a rare case of interstitial pneumonitis following COVID-19 mRNA vaccination.
Interstitial pneumonitis mRNA vaccine Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Received 14 Jan 2022 / Accepted 25 Feb 2022
AJRS, 11(3): 143-147, 2022